1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
Meng, X.; Lou, Q.Y.; Yang, W.Y.; Wang, Y.R.; Chen, R.; Wang, L.; Xu, T.; Zhang, L. The role of non-coding RNAs in drug resistance
of oral squamous cell carcinoma and therapeutic potential. Cancer Commun. 2021, 41, 981–1006. [CrossRef]
Thomson, P.J. Perspectives on oral squamous cell carcinoma prevention-Proliferation, position, progression and prediction. J. Oral
Pathol. Med. 2018, 47, 803–807. [CrossRef]
Chen, S.W.; Chou, C.T.; Chang, C.C.; Li, Y.J.; Chen, S.T.; Lin, I.C.; Kok, S.H.; Cheng, S.J.; Lee, J.J.; Wu, T.S.; et al. HMGCS2 enhances
invasion and metastasis via direct interaction with PPARα to activate Src signaling in colorectal cancer and oral cancer. Oncotarget.
2017, 8, 22460–22476. [CrossRef]
Annesley, S.J.; Fisher, P.R. Mitochondria in health and disease. Cells 2019, 8, 680. [CrossRef]
Sharma, P.; Sampath, H. Mitochondrial DNA integrity: Role in health and disease. Cells 2019, 8, 100. [CrossRef]
Kausar, S.; Wang, F.; Cui, H. The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells 2018, 7, 274. [CrossRef]
Song, S.; Pursell, Z.F.; Copeland, W.C.; Longley, M.J.; Kunkel, T.A.; Mathews, C.K. DNA precursor asymmetries in mammalian
tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity. Proc. Natl. Acad. Sci. USA
2005, 102, 4990–4995. [CrossRef] [PubMed]
Bai, J.; Wu, L.; Wang, X.; Wang, Y.; Shang, Z.; Jiang, E.; Shao, Z. Roles of mitochondria in oral squamous cell carcinoma therapy:
Friend or foe? Cancers 2022, 14, 5723. [PubMed]
Takeda, D.; Hasegawa, T.; Ueha, T.; Sakakibara, A.; Kawamoto, T.; Minamikawa, T.; Sakai, Y.; Komori, T. Decreased mitochondrial
copy numbers in oral squamous cell carcinoma. Head Neck 2016, 38, 1170–1175. [CrossRef]
Ventura-Clapier, R.; Garnier, A.; Veksler, V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1alpha.
Cardiovasc. Res. 2008, 79, 208–217. [PubMed]
Tao, L.; Park, J.Y.; Lambert, J.D. Differential prooxidative effects of the green tea polyphenol, (–)-epigallocatechin-3-gallate, in
normal and oral cancer cells are related to differences in sirtuin 3 signaling. Mol. Nutr. Food Res. 2015, 59, 203–211. [CrossRef]
Bause, A.S.; Haigis, M.C. SIRT3 regulation of mitochondrial oxidative stress. Exp. Gerontol. 2013, 48, 634–639. [CrossRef]
Kong, X.; Wang, R.; Xue, Y.; Liu, X.; Zhang, H.; Chen, Y.; Fang, F.; Chang, Y. Sirtuin 3, a new target of PGC-1alpha, plays an
important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010, 5, e11707. [CrossRef]
Cancers 2023, 15, 4071
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
14 of 15
Zhou, X.; Temam, S.; Oh, M.; Pungpravat, N.; Huang, B.L.; Mao, L.; Wong, D.T. Global expression-based classification of lymph
node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 2006, 8, 925–932. [CrossRef]
[PubMed]
Ding, X.; Zhang, N.; Cai, Y.; Li, S.; Zheng, C.; Jin, Y.; Yu, T.; Wang, A.; Zhou, X. Down-regulation of tumor suppressor MTUS1/ATIP
is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol.
Oncol. 2012, 6, 73–80. [CrossRef]
Lai, C.C.; Lin, P.M.; Lin, S.F.; Hsu, C.H.; Lin, H.C.; Hu, M.L.; Hsu, C.M.; Yang, M.Y. Altered expression of SIRT gene family in
head and neck squamous cell carcinoma. Tumor Biol. 2013, 34, 1847–1854. [CrossRef]
Mitra, S.; Izumi, T.; Boldogh, I.; Bhakat, K.K.; Hill, J.W.; Hazra, T.K. Choreography of oxidative damage repair in mammalian
genomes. Free. Radic. Biol. Med. 2002, 33, 15–28. [CrossRef]
Kohno, T.; Shinmura, K.; Tosaka, M.; Tani, M.; Kim, S.R.; Sugimura, H.; Nohmi, T.; Kasai, H.; Yokota, J. Genetic polymorphisms
and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998,
16, 3219–3225. [CrossRef]
Paz-Elizur, T.; Krupsky, M.; Blumenstein, S.; Elinger, D.; Schechtman, E.; Livneh, Z. DNA repair activity for oxidative damage and
risk of lung cancer. J. Natl. Cancer Inst. 2003, 95, 1312–1319. [CrossRef]
Gangwar, R.; Ahirwar, D.; Mandhani, A.; Mittal, R.D. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on
susceptibility to bladder cancer in the north Indian population? Mutat. Res. 2009, 680, 56–63. [CrossRef] [PubMed]
Sova, H.; Jukkola-Vuorinen, A.; Puistola, U.; Kauppila, S.; Karihtala, P. 8-hydroxydeoxyguanosine: A new potential independent
prognostic factor in breast cancer. Br. J. Cancer 2010, 102, 1018–1023. [CrossRef]
Paz-Elizur, T.; Ben-Yosef, R.; Elinger, D.; Vexler, A.; Krupsky, M.; Berrebi, A.; Shani, A.; Schechtman, E.; Freedman, L.; Livneh, Z.
Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res. 2006, 66, 11683–11689.
[CrossRef]
Brieleyt, J.D.; Gospodarowicz, M.K.; Wittekind, C. TNM Classification of Malignant Tumors, 8th ed.; Willey Blackwell: Hoboken, NJ,
USA, 2017; p. 272.
Wang, Z.; Choi, S.; Lee, J.; Huang, Y.T.; Chen, F.; Zhao, Y.; Lin, X.; Neuberg, D.; Kim, J.; Christiani, D.C. Mitochondrial variations
in non-small cell lung cancer (NSCLC) survival. Cancer Inform. 2015, 14 (Suppl. S1), CIN-S13976. [CrossRef] [PubMed]
Koc, E.C.; Haciosmanoglu, E.; Claudio, P.P.; Wolf, A.; Califano, L.; Friscia, M.; Cortese, A.; Koc, H. Impaired mitochondrial protein
synthesis in head and neck squamous cell carcinoma. Mitochondrion 2015, 24, 113–121. [CrossRef]
Zu, Y.; Chen, X.F.; Li, Q.; Zhang, S.T.; Si, L.N. PGC-1α activates SIRT3 to modulate cell proliferation and glycolytic metabolism in
breast cancer. Neoplasma 2021, 68, 352–361. [CrossRef]
Cheng, Y.; Ren, X.; Gowda, A.S.; Shan, Y.; Zhang, L.; Yuan, Y.S.; Patel, R.; Wu, H.; Huber-Keener, K.; Yang, J.W.; et al. Interaction
of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress.
Cell Death Dis. 2013, 4, e731. [CrossRef]
Hallberg, B.M.; Larsson, N.G. TFAM forces mtDNA to make a U-turn. Nat. Struct. Mol. Biol. 2011, 18, 1179–1181. [CrossRef]
Zhu, Y.; Xu, J.; Hu, W.; Wang, F.; Zhou, Y.; Xu, W.; Gong, W.; Shao, L. TFAM depletion overcomes hepatocellular carcinoma
resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction. Gene 2020, 753, 144807.
[CrossRef]
Zhu, Y.; Yan, Y.; Principe, D.R.; Zou, X.; Vassilopoulos, A.; Gius, D. SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins
that connect mitochondrial metabolism and carcinogenesis. Cancer Metab. 2014, 2, 15. [PubMed]
Nakayama, Y.; Yamauchi, M.; Minagawa, N.; Torigoe, T.; Izumi, H.; Kohno, K.; Yamaguchi, K. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer. Oncol. Rep. 2012, 27, 1325–1330. [CrossRef]
Gao, W.; Wu, M.; Wang, N.; Zhang, Y.; Hua, J.; Tang, G.; Wang, Y. Increased expression of mitochondrial transcription factor A
and nuclear respiratory factor-1 predicts a poor clinical outcome of breast cancer. Oncol. Lett. 2018, 15, 1449–1458. [CrossRef]
Hsieh, Y.T.; Tu, H.F.; Yang, M.H.; Chen, Y.F.; Lan, X.Y.; Huang, C.L.; Chen, H.M.; Li, W.C. Mitochondrial genome and its regulator
TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic
effectors. Cell Death Dis. 2021, 12, 961. [CrossRef]
Urra, F.A.; Fuentes-Retamal, S.; Palominos, C.; Rodríguez-Lucart, Y.A.; López-Torres, C.; Araya-Maturana, R. Extracellular matrix
signals as drivers of mitochondria bioenergetics and metabolic plasticity of cancer cells during metastasis. Front. Cell Dev. Biol.
2021, 9, 751301. [CrossRef]
Valcarcel-Jimenez, L.; Macchia, A.; Crosas-Molist, E.; Schaub-Clerigué, A.; Camacho, L.; Martín-Martín, N.; Cicogna, P.; VieraBardón, C.; Fernández-Ruiz, S.; Rodriguez-Hernandez, I.; et al. PGC1α suppresses prostate cancer cell invasion through ERRα
transcriptional control. Cancer Res. 2019, 79, 6153–6165. [CrossRef]
Signorile, A.; De Rasmo, D.; Cormio, A.; Musicco, C.; Rossi, R.; Fortarezza, F.; Palese, L.L.; Loizzi, V.; Resta, L.; Scillitani, G.;
et al. Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling. Cancers 2019, 11, 1350.
[CrossRef]
Cheng, C.F.; Ku, H.C.; Lin, H. PGC-1α as a pivotal factor in lipid and metabolic regulation. Int. J. Mol. Sci. 2018, 19, 3447.
[CrossRef]
Zanoni, D.K.; Montero, P.H.; Migliacci, J.C.; Shah, J.P.; Wong, R.J.; Ganly, I.; Patel, S.G. Survival outcomes after treatment of cancer
of the oral cavity (1985–2015). Oral Oncol. 2019, 90, 115–121. [CrossRef] [PubMed]
Cancers 2023, 15, 4071
39.
40.
41.
15 of 15
Jones, H.B.; Sykes, A.; Bayman, N.; Sloan, P.; Swindell, R.; Patel, M.; Musgrove, B. The impact of lymphovascular invasion on
survival in oral carcinoma. Oral Oncol. 2009, 45, 10–15. [CrossRef] [PubMed]
Huang, S.; Zhu, Y.; Cai, H.; Zhang, Y.; Hou, J. Impact of lymphovascular invasion in oral squamous cell carcinoma: A meta-analysis.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2021, 131, 319–328.e1.
Fives, C.; Feeley, L.; O’Leary, G.; Sheahan, P. Importance of lymphovascular invasion and invasive front on survival in floor of
mouth cancer. Head Neck 2016, 38 (Suppl. S1), E1528–E1534. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
...
論文の公開元へ
